I reported previously (see here) on Israeli biotech Ayala and its personalized cancer treatment. It is already partnering with Bristol-Myers Squibb. Now multinational Novartis has made a $|10 million investment in Ayala, focusing on the aggressive blood cancer multiple myeloma.

https://www.calcalistech.com/ctech/articles/0,7340,L-3752698,00.html